Heart disease kills 18 million people each year, but the development of new therapies faces a bottleneck: no physiological model of the entire human heart exists – so far. A new multi-chamber organoid ...

New ACC/AHA guidelines update management of adults with congenital heart defects but highlight the shortage of specialists ...

Cardiovascular diseases (CVDs) remain the leading cause of death worldwide. Several risk factors, including genetics, sex, and age, increase the risk of CVDs. Other factors that contribute to CVD ...

An advanced human heart organoid system can be used to model embryonic heart development under pregestational diabetes-like conditions, researchers report. The organoids recapitulate hallmarks of ...

Though an estimated 60 million people around the world have atrial fibrillation, or A-fib, a type of irregular and often fast ...

In a decades-long effort, researchers have discovered how to tweak the molecular pathways that turn heart muscle motors up or ...

Using a combination for spatial, single-cell transcriptomics and imaging data from 36 hearts, scientists from the KTH Royal Institute of Technology and their collaborators have come up with what they ...

An international team of researchers has discovered a natural mechanism that protects the heart from heart failure with preserved ejection fraction (HFpEF), a serious condition in need of effective ...

Share on Pinterest Research shows that poor heart health may put people at risk of multiple musculoskeletal disorders. Ronald Martinez/Getty Images Researchers investigated the link between ...

Tenaya Therapeutics is advancing two one-time gene therapies, TN-201 and TN-401, targeting genetic heart disorders with key data readouts expected in Q4 2025. Interim results for TN-201 in MYBPC3-HCM ...